![Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.02273-21/asset/c7aef656-1c7a-4a39-bf66-bee1987117c9/assets/images/large/aac.02273-21-f006.jpg)
Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy
![New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms](https://mma.prnewswire.com/media/1704248/GLADSKIN_Endolysin_Staphefekt.jpg?p=facebook)
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
![Introducing Gladskin Eczema Cream with Micreobalance™: A Swiss Scientific Breakthrough that Reduces Eczema Itch and Redness, Moisturizes while Rebalancing the Skin Microbiome in a Smarter and Safe... | Markets Insider Introducing Gladskin Eczema Cream with Micreobalance™: A Swiss Scientific Breakthrough that Reduces Eczema Itch and Redness, Moisturizes while Rebalancing the Skin Microbiome in a Smarter and Safe... | Markets Insider](https://mma.prnewswire.com/media/1062241/Gladskin_Eczema_Cream_with_Micreobalance.jpg)
Introducing Gladskin Eczema Cream with Micreobalance™: A Swiss Scientific Breakthrough that Reduces Eczema Itch and Redness, Moisturizes while Rebalancing the Skin Microbiome in a Smarter and Safe... | Markets Insider
![Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine](https://www.microbiometimes.com/wp-content/uploads/2020/09/shutterstock_1513340948-2-678x381.jpg)
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine
![New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms](https://mma.prnewswire.com/media/1704248/GLADSKIN_Endolysin_Staphefekt.jpg?w=200)
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
![BBC Two - Trust Me, I'm a Doctor, Series 6, Episode 2 - Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics? BBC Two - Trust Me, I'm a Doctor, Series 6, Episode 2 - Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics?](https://ichef.bbci.co.uk/images/ic/480xn/p04rkbc4.jpg)
BBC Two - Trust Me, I'm a Doctor, Series 6, Episode 2 - Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics?
Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis - JDDonline - Journal of Drugs in Dermatology
![Full article: Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection Full article: Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection](https://www.tandfonline.com/cms/asset/59da7a28-722b-4fb0-a4a6-6c8b17a3dd24/kgmi_a_1813533_f0001_oc.jpg)